Home About us Reports Pre-sale News Stock Market Database Custom Company Scan



 researchinchina > report > Life Sciences > Pharmaceutical > report

Company Study of Guangxi Wuzhou Zhongheng Group

Published: Aug/2007

Hard Copy  USD $ 349
Pages: 23 Electronic(PDF)  USD $ 349
Report Code: Enterprisewide  USD $ 698
 

In 2006, the company received the main business revenue of RMB 321.1685 million, of which the pharmaceutical industry accounted for 62.83%; the profit of main business reached RMB 154.1201 million and, the net profit amounted to RMB 19.6635 million.

Xueshuantong Freeze-Dry Powder for Injection, the company's core pharmaceutical product, is an important variety in cardiovascular and cerebrovascular fields. At present, the company's full-loaded monthly production capacity can not meet the increased market demand, so some products are contracted to Chongqing Yaoyou Pharmaceutical temporarily. It is estimated that the sales volume of Xueshuantong Freeze-Dry Powder for Injection will be 25 million doses in 2007, and 40 million in 2008, 50 million in 2009.

Main Business Structure of Zhongheng Group, 2006


 

Market Pattern of Drugs Used in Hospitals, 2006


 



If this report could not still meet your requirement, or you have any comments or suggestions on it, please leave a message to us.
 
2005-2007 www.researchinchina.com All Rights Reserved